News

The strategic acquisition allows NuVasive the potential to accelerate its entry into the growing mechanical cervical disc replacement market, said NuVasive. The initial payment for purchase of Cervitech

Watson said that its guaifenesin and dextromethorphan HBr/guaifenesin extended-release tablet products are the generic versions of Reckitt Benckiser’s Mucinex and Mucinex DM products which are indicated to help

The design for the double-blind, placebo-controlled Phase II exploratory study of TC-5214 provides for approximately 12 subjects with resistant hypertension to receive either a single escalating dose of

Dr Yu is a distinguished research fellow and associate director at the Genomics Research Center, Academia Sinica, in Taiwan. She also serves as a professor of pediatrics for

The patent generally claims methods for treating Alzheimer’s disease comprising administering scyllo-inositol (ELND005). The patent will expire in the year 2025 or later due to any patent term

Hawk IR will continue to operate as Hawk IR International under the Fluke electronics industrial division and will continue to service its customers and partners globally. Fluke said

Under the research collaboration with professor Jack Schalken (laboratory of experimental urology), InteRNA’s lentiviral-based microRNA (miRNA) overexpression library will be applied in multi-parametric, high-throughput functional screening assays to

Currently Sherman is a senior vice president and general manager. He will report to John E. McGlade, chairman, president and chief executive officer. He will have responsibility for

The primary objective of this multicenter, randomized, placebo-controlled, crossover study is the assessment of safety, tolerability and efficacy of ARX-02 relative to placebo in cancer patients experiencing episodic